Leveraging AI and Genetics to Transform HRT for Better Patient Outcomes

​Standard testosterone protocols are NOT inherently UNSAFE…

​But for some women, they are biologically incompatible.

​In this live webinar, we will examine a real anonymized female HRT case scenario where “normal” testosterone dosing led to unexpected androgenic side effects despite labs appearing acceptable by conventional standards.

​Using genetics, biomarkers, and systems-level reasoning, we’ll unpack why this happened and how similar outcomes can be predicted earlier.

​What we’ll discuss:

• ​A real case scenario where testosterone therapy triggered complications despite standard dosing

• ​Why total testosterone alone is an insufficient safety marker in women

• ​How specific genetic variants increase conversion to DHT and amplify androgenic risk

• ​When estrogen risk variants should fundamentally alter HRT decision-making

• ​How AI-driven pattern recognition can surface risks that traditional reviews miss